Tag: Pfizer
HALO Gearing Up For A Rebound In 2013?
Investors holding shares of biotech Halozyme Therapeutics (HALO) awoke to excellent news Friday morning. The company announced it had entered into a worldwide collaboration and licensing agreement with Pfizer (PFE). The deal gives Pfizer a global license to develop and market products using Halozyme’s revolutionary Enhanze drug delivery technology. I’ll tell you all about this […]
Should You Still Hold Pfizer?
A little over a year ago, I started buying shares of Pfizer (PFE). It was a scary time in the markets. We’d just entered a major economic downturn. The credit crisis was in full swing. And the major market indices were falling fast. Despite the bearish conditions, I found a company I believed had long […]
Is This Hedge Fund Strategy For You?
As you may remember from my articles last week, every year I take a ski trip. My skiing buddies are a group of well connected investment bankers, CEOs, and venture capitalists. Two years ago we were in Vail. Last year it was Telluride. This year, Aspen. After four days in the mountains, I was happy […]
Pfizer Cuts The Dividend… Now What?
The alarm went off early this morning. It always does on Mondays. Five more minutes I told myself… five more minutes. The next thing I know I’m running late. Damn snooze button. I quickly jumped into the shower. Then, like always, I turn on CNBC. I do it every morning when I’m getting ready. With […]
A Drug Stock To Buy Now
Just a few weeks ago I started buying for my own account. I sensed a bottom might be forming in the market. I didn’t time it perfectly, but I’m up on these investments so far. Back in December I wrote about one of my picks. If you missed that article you can check it out […]
An Undervalued Blue Chip
Last Saturday morning I was sitting at the breakfast table reading the paper. For me, it’s always the business section first. The news was nothing new. The same old rehashed commentary on the performance of the markets. I don’t need anyone to tell me October was a horrible month. You’ll note from peak to trough […]
